Ongoing
Closed
Exploratory evaluation of her2 as a potential new therapeutic target in soft tissue sarcomas
Sun Jan 1, 2023
Identification of circulating "molecular signaling" capable of predicting tumor dissemination in the bone marrow in patients with early breast cancer
Thu 1th Sep 2022, p.m. CEST
Role of the intestinal microbiota in treatment with cyclin-dependent kinase inhibitor drugs in metastatic breast cancer
Tue 1 Mar, 2022
Role of oral microbiota as a potential predictor of response to immunotherapy treatments in non-small cell lung cancer
Mon Nov 1, 2021
Synergy between cyclin inhibitors and trabectedin in soft tissue sarcoma and breast cancer cell models
Fri Oct 1, 2021
Identification of new therapeutic targets in patients affected by trabectedin-resistant soft tissue sarcomas
Wed 1 Jul, 2020
Identification of molecular and cellular profiles predictive of efficacy to immunotherapies in advanced solid tumors
Sun Sep 1, 2019
Novel non-invasive approaches to identify biomarkers of response to immunotherapies in non-small cell lung cancer
Tue 1 Jan, 2019
Effects of cyclin-dependent kinase inhibitors (CDK4/6) on pre-clinical models of bone metastases from breast cancer
Mon 1 Oct, 2018
Identification of circulating biomarkers predictive of response to immunotherapies in patients with clear cell renal cell carcinoma
Mon Jan 1, 2018
